Féray C - Search Results

1

Donor HLA Class 1 Evolutionary Divergence Is a Major Predictor of Liver Allograft Rejection : A Retrospective Cohort Study.

Féray C, Taupin JL, Sebagh M, Allain V, Demir Z, Allard MA, Desterke C, Coilly A, Saliba F, Vibert E, Azoulay D, Guettier C, Chatton A, Debray D, Caillat-Zucman S, Samuel D. Féray C, et al. Ann Intern Med. 2021 Oct;174(10):1385-1394. doi: 10.7326/M20-7957. Epub 2021 Aug 24. Ann Intern Med. 2021. PMID: 34424731

2

Reinfection of liver graft by hepatitis C virus after liver transplantation.

Féray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, Reynes M, Maisonneuve P, Bismuth H, Bréchot C. Féray C, et al. J Clin Invest. 1992 Apr;89(4):1361-5. doi: 10.1172/JCI115723. J Clin Invest. 1992. PMID: 1313453 Free PMC article.

3

The Paul Brousse liver transplant series 1989 to 1992: new trends in the last four years.

Bismuth H, Samuel D, Castaing D, Adam R, Chiche L, Johann M, Azoulay D, Farges O, Feray C, Rucay P, et al. Bismuth H, et al. Among authors: feray c. Clin Transpl. 1992:161-6. Clin Transpl. 1992. PMID: 1339127

4

[Relapse prevention in liver transplant patients treated for liver involvement due to hepatitis B virus].

Bismuth A, Arulnaden JL, Samuel D, David MF, Pichon F, Mathieu D, Farahmand H, Farrokhi P, Feray C, Brechot C, et al. Bismuth A, et al. Among authors: feray c. Rev Fr Transfus Hemobiol. 1992 Mar;35(2):107-23. doi: 10.1016/s1140-4639(05)80111-x. Rev Fr Transfus Hemobiol. 1992. PMID: 1637419 French.

5

[Clinical and virological aspects of hepatitis C virus infection in liver transplantation].

Féray C, Samuel D, Reynès M, Bismuth H. Féray C, et al. Gastroenterol Clin Biol. 1995 Mar;19(3):297-301. Gastroenterol Clin Biol. 1995. PMID: 7540159 Review. French. No abstract available.

6

Liver transplantation for viral hepatitis: the experience of the hepatobiliary center at Hospital Paul Brousse.

Samuel D, Feray C, Bismuth H. Samuel D, et al. Among authors: feray c. Clin Transpl. 1994:157-62. Clin Transpl. 1994. PMID: 7547534

7

An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection.

Féray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reynès M, Bismuth H. Féray C, et al. Hepatology. 1995 Oct;22(4 Pt 1):1084-9. Hepatology. 1995. PMID: 7557855 Clinical Trial.

8

[Evaluation of results of liver transplantation: experience based on a series of 1052 transplantations].

Bismuth H, Farges O, Castaing D, Samuel D, Adam R, Johann M, Azoulay D, Feray C, Astarcioglu I, Saliba F. Bismuth H, et al. Among authors: feray c. Presse Med. 1995 Jul 1-8;24(24):1106-14. Presse Med. 1995. PMID: 7567817 French.

9

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.

Féray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynés M, Okamoto H, Bismuth H, Bréchot C. Féray C, et al. Gastroenterology. 1995 Apr;108(4):1088-96. doi: 10.1016/0016-5085(95)90207-4. Gastroenterology. 1995. PMID: 7698576

10

[Viral hepatitis and liver transplantation].

Samuel D, Féray C, Bismuth H. Samuel D, et al. Among authors: feray c. Rev Prat. 1995 Jan 15;45(2):197-201. Rev Prat. 1995. PMID: 7725022 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters